| Recovery of bioactive protein from bacterial inclusion bodies using trifluoroethanol as solubilization agent V Upadhyay, A Singh, D Jha, A Singh, AK Panda Microbial cell factories 15, 1-13, 2016 | 51 | 2016 |
| Structure-function relationship of inclusion bodies of a multimeric protein A Singh, V Upadhyay, A Singh, AK Panda Frontiers in Microbiology 11, 876, 2020 | 26 | 2020 |
| In situ vaccination with nanoparticles for cancer immunotherapy: understanding the immunology C Mao, MJ Gorbet, A Singh, A Ranjan, S Fiering International Journal of Hyperthermia 37 (3), 4-17, 2020 | 17 | 2020 |
| Molecular attributes associated with refolding of inclusion body proteins using the freeze–thaw method P Singhvi, J Verma, N Panwar, TQ Wani, A Singh, M Qudratullah, ... Frontiers in Microbiology 12, 618559, 2021 | 14 | 2021 |
| Using nanoparticles for in situ vaccination against cancer: mechanisms and immunotherapy benefits MJ Gorbet, A Singh, C Mao, S Fiering, A Ranjan International Journal of Hyperthermia 37 (3), 18-33, 2020 | 14 | 2020 |
| Focused ultrasound ablation of a large canine oral tumor achieves efficient tumor remission: a case report A Ranjan, D Kishore, H Ashar, T Neel, A Singh, S More International Journal of Hyperthermia 38 (1), 552-560, 2021 | 8 | 2021 |
| Enabling chemo-immunotherapy with HIFU in canine cancer patients H Ashar, A Singh, D Kishore, T Neel, S More, C Liu, D Dugat, A Ranjan Annals of biomedical engineering 52 (7), 1859-1872, 2024 | 6 | 2024 |
| Treating methicillin-resistant Staphylococcus aureus (MRSA) bone infection with focused ultrasound combined thermally sensitive liposomes H Ashar, A Singh, K Ektate, S More, A Ranjan International Journal of Hyperthermia 40 (1), 2211278, 2023 | 5 | 2023 |
| Adrenergic receptor signaling regulates the CD40-receptor mediated anti-tumor immunity A Singh, A Ranjan Frontiers in immunology 14, 1141712, 2023 | 5 | 2023 |
| Age-associated changes in the gut microbiome impact efficacy of tumor immunomodulatory treatments A Singh, H Ashar, JT Butcher, A Ranjan Experimental gerontology 181, 112268, 2023 | 3 | 2023 |
| Overcoming resistance to immune checkpoint inhibitor therapy using calreticulin-inducing nanoparticle SV Chandrasekar, A Singh, A Ranjan Pharmaceutics 15 (6), 1693, 2023 | 1 | 2023 |
| Recent developments in clinical biomarkers for cancer prognosis, prediction, treatment, and their clinical utility A Singh, A Ashok, S Pandey, Q Lin Frontiers in Genetics 15, 1437556, 2024 | | 2024 |
| Targeted Delivery of Glucose Oxidase Prolongs Survival of a Mouse Prostate Tumor Model S Manouchehri, A Singh, A Ranjan, J Ramsey 2023 AIChE Annual Meeting, 2023 | | 2023 |
| Age associated tumor microenvironment induces differential outcomes from immunomodulatory nanoparticles and therapeutic ultrasound in murine melanoma A Singh, JF Oliveira, S Fiering, J Butcher, NF Steinmetz, A Ranjan Cancer Research 83 (7_Supplement), 2338-2338, 2023 | | 2023 |
| Sexual dimorphism induces differential immunomodulatory outcomes from local nanoparticle and focused ultrasound therapy in murine model of head and neck cancer SV Chandrasekar, A Singh, A Ranjan Cancer Research 83 (7_Supplement), 2741-2741, 2023 | | 2023 |
| Structure-Function Relationship of Inclusion Bodies of a Multimeric Protein AK Panda, V Upadhyay, A Singh, A Singh Frontiers Media SA, 2020 | | 2020 |
| Final Report FUS Grant H Ashar, D Kishore, D Dugat, A Singh, A Ranjan OSF, 0 | | |
| FUS Canine Cancer Project H Ashar, D Kishore, D Dugat, A Singh, T Neel, S More, A Ranjan OSF, 0 | | |
Amulya K PandaAssociate Director, Panacea Biotec Ltd and Former Director, National Inst of Immunology, New Delhi在 panaceabiotec.com 的电子邮件经过验证
